Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromas, Cutaneous”

Showing 8 of 0 results

Early research (Phase 1)Study completedNCT06132165
What this trial is testing

Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 13
Testing effectiveness (Phase 2)Study completedNCT03090971
What this trial is testing

Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
Fundação Educacional Serra dos Órgãos 7
Testing effectiveness (Phase 2)Study completedNCT02332902
What this trial is testing

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

Who this might be right for
Neurofibromatosis 1
The University of Texas Health Science Center, Houston 24
Early research (Phase 1)Study completedNCT00865644
What this trial is testing

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Who this might be right for
Neurofibromatosis Type 1Cutaneous Neurofibromas
Massachusetts General Hospital 11
Not applicableStudy completedNCT05119582
What this trial is testing

HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy

Who this might be right for
Cutaneous Neurofibroma
Joergen Serup 20
Not applicableStudy completedNCT02777775
What this trial is testing

Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

Who this might be right for
Cutaneous NeurofibromasNeurofibromatosis Type 1Plexiform Neurofibromas
Corewell Health West 71
Early research (Phase 1)Study completedNCT06120036
What this trial is testing

Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Who this might be right for
Neurofibromatosis 1
Massachusetts General Hospital 20
Early research (Phase 1)Study completedNCT01682811
What this trial is testing

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Who this might be right for
Neurofibromatoses
Harry T Whelan, MD 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation